OTCPicks.com Stocks to Watch for Tuesday, March 24th PIR, SSTP, MRNA, NGSX, WAMUQ

Our Stocks to Watch tomorrow include Pier 1 Imports Inc. (NYSE: PIR), Sustainable Power Corp. (OTC: SSTP), MDRNA Inc. (Nasdaq: MRNA), NeurogesX Inc. (Nasdaq: NGSX) and Washington Mutual Inc. (OTC: WAMUQ).

PIER ONE INCORPORATED (NYSE: PIR)

"Up 275.00% on Monday"

Pier 1 Imports, Inc., together with its subsidiaries, operates as a specialty retailer of imported decorative home furnishings, gifts, and related items in the United States and Canada. Its stores offer furniture, wicker, decorative home furnishings, dining and kitchen goods, epicurean products, bath and bedding accessories, candles, and other specialty items for the home. The company’s decorative accessories include wood accessories, lamps, vases, dried and artificial flowers, baskets, wall decorations, ceramics, dinnerware, bath and fragrance products, candles, bedding, epicurean products, and seasonal and gift items. Its furniture products comprise furniture and furniture cushions to be used on patios, and in living, dining, kitchen, bedroom, and sunrooms. As of March 1, 2008, the company operated 1,117 stores under Pier 1 Imports name. Pier 1 Imports, Inc. also operates in Mexico and Puerto Rico. The company was founded in 1970 and is headquartered in Fort Worth, Texas.

SUSTAINABLE POWER CORPORATION (OTC: SSTP)

"Up 81.82% on Monday"

Sustainable Power Corp. is an international green energy total service provider focused on producing environmentally friendly jet fuel, gasoline, diesel and marine fuel meeting all petroleum ASTM standards. The company has developed and manages a portfolio of green, non-food, agricultural feed stock to produce a revolutionary bio-crude which all jet, diesel, and gasoline engines can utilize without any modifications. Visit www.sstp.us for more information.

MDRNA INCORPORATED (NASDAQ: MRNA)

"Up 59.26% on Monday"

MDRNA is a biotechnology company focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). Our goal is to improve human health through the development of RNAi-based compounds and drug delivery technologies that together provide superior therapeutic options for patients. Over the past decade, we have developed substantial capabilities in molecular biology, cellular biology, lipid chemistry, peptide chemistry, pharmacology and bioinformatics, which we are applying to a wide range of RNAi technologies and delivery approaches. These capabilities plus the in-licensing of key RNAi-related intellectual property have rapidly enabled us to become a leading RNAi-based therapeutics company with a pre-clinical pipeline in key therapeutic areas including oncology, metabolic disorders and inflammation. Through our capabilities, expertise and know-how, we are incorporating multiple RNAi technologies as well as peptide- and lipid-based delivery approaches into a single integrated drug discovery platform that will be the engine for our clinical pipeline as well as a versatile platform for establishing broad therapeutic partnerships with biotechnology and pharmaceutical companies. We are also investing in new technologies that we expect to lead to safer and more effective RNAi-based therapeutics while aggressively building upon our broad and extensive intellectual property estate. By combining broad expertise in siRNA science with proven delivery platforms and a strong IP position, MDRNA is well positioned as a leading RNAi-based drug discovery and development company.

NEUROGESX INCORPORATED (NASDAQ: NGSX)

"Up 12.90% on Monday"

NeurogesX is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions, that the Company believes offers significant advantages over other pain therapies. NeurogesX' marketing authorization application (MAA) to the European Medicines Agency (EMEA) was accepted for review in September 2007 and NeurogesX submitted a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) in October, 2008 for PHN. NeurogesX' second most advanced product candidate, NGX-1998, is a topically applied, liquid formulation containing a high concentration of capsaicin designed to treat pain associated with neuropathic pain conditions. NGX-1998 is currently in a Phase 1 clinical trial. The objective of the development program for NGX-1998 is to determine its ability to provide protracted pain relief from a single treatment. As a liquid, NGX-1998 is expected to be suitable for areas of the skin where dermal patches may be difficult or impractical to apply, such as the hairline. NGX-1998 is being developed with the goal of it becoming a product that has the potential to be used by a broad spectrum of the physician population. NGX-1998 was previously studied in two Phase 1 studies in healthy volunteers conducted under an exploratory investigational new drug application.

WASHINGTON MUTUAL INCORPORATED (OTC: WAMUQ)

"Up 43.53% on Monday"

Washington Mutual, Inc., together with its subsidiaries, operates as a consumer and small business banking company in the United States. It operates in four segments: Retail Banking Group, Card Services Group, Commercial Group, and Home Loans Group. The Retail Banking Group segment offers deposit and other retail banking products and services, which include checking and interest-bearing checking, personal checking, savings, money market deposit, and time deposit accounts to consumers and small businesses; loan products comprising home loans, home equity loans, home equity lines of credit, and mortgage loans; and investment advisory and brokerage services. The Card Services Group segment’s operations consist of issuing credit cards, holding outstanding balances on credit cards in portfolio or securitizing and selling them, servicing credit card accounts, and providing other cardholder services. The Commercial Group segment provides finance to developers and investors for multi family dwellings and other commercial properties, services multi family and other commercial real estate loans, and provides limited deposit services to commercial customers. The Home Loans Group segment originates, fulfills, and services home loans, and home equity loans and lines of credit; manages capital market operations; and holds the company’s held for investment portfolios of home loans, home equity loans, and home equity lines of credit made to higher risk borrowers through the subprime mortgage channel. As of December 31, 2007, the company operated 2,257 retail banking stores and 233 lending stores and centers in 36 states. Washington Mutual, Inc. was founded in 1889 and is headquartered in Seattle, Washington. On September 26, 2008, Washington Mutual Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware.

About OTCPicks.com

OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.